Retatrutide (GLP-3) represents an advanced class of research peptides functioning as a dual-agonist/triple-agonist targeting the GIP, GLP-1, and glucagon receptors. This multi-pathway mechanism makes it a crucial compound for clinical research surrounding metabolic signaling pathways, energy regulation, and advanced biochemical assays. Meridian Peptide Co. supplies this synthetic peptide at an exceptional 99% purity level, ensuring stable molecular integrity and highly consistent, reproducible results across complex laboratory evaluations.
To maintain maximum chemical stability, our Retatrutide is prepared in a stable, lyophilized powder format that must be kept refrigerated at temperatures between 2–8°C ($35–46°F$). In strict adherence to scientific standards, this product is documented and distributed exclusively for laboratory research and in vitro evaluation only. It is explicitly not intended for human consumption, therapeutic diagnostics, or any form of veterinary application.


Reviews
There are no reviews yet.